Literature DB >> 32647414

The Effect of miR-98 and miR-214 on Apoptotic and Angiogenic Pathways in Hepatocellular Carcinoma HepG2 Cells.

Shaymaa M M Yahya1, Shereen M M Yahya1.   

Abstract

Hepatocellular carcinoma (HCC) is one of the foremost causes of cancer related morbidity worldwide. An increasing number of studies have confirmed that microRNAs play an important role in the development, progression and metastasis of HCC. From those important miRNAs are miR-98 and miR-214. This study were conducted to explore the effect of these two miRNAs on some apoptotic and angiogenic genes namely, BCL-2, survivin, CCND1, CDC2, P53 and P21, VEGF, Hif-1α, MMP-2, MMP-9, Ang-1, Ang-2, and FGF-1. miRNAs mimics and inhibitors transfection was used to investigate the role of both studied molecules in apoptosis and angiogenesis in HepG2 cells. QRT-PCR was used for Quantitative gene and miRNA expression analyses. The study revealed that miR-98 could serve as a pro-apoptotic factor through the upregulation of P53 gene expression levels. Besides, the anti-angiogenic effect of this miRNA was evident through the down regulation of Ang-1 and FGF-1 genes. Meanwhile, miR-214 showed a pro-apoptotic role and anti-angiogenic effects. These effects were verified through the significant down regulation of BCL-2, CDC2, VEGF, Ang-1 and MMP-2. These results introduced a possible positive role played by both miR-98 and miR-214 on some pro-apoptotic and anti-angiogenic genes. © Association of Clinical Biochemists of India 2019.

Entities:  

Keywords:  Angiogenesis; Apoptosis; Hepatocellular carcinoma; miR-214; miR-98

Year:  2019        PMID: 32647414      PMCID: PMC7326845          DOI: 10.1007/s12291-019-00824-1

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  34 in total

1.  Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways.

Authors:  Cecilia Scisciani; Stefania Vossio; Francesca Guerrieri; Valeria Schinzari; Rossana De Iaco; Paolo D'Onorio de Meo; Melchiorre Cervello; Giuseppe Montalto; Teresa Pollicino; Giovanni Raimondo; Massimo Levrero; Natalia Pediconi
Journal:  J Hepatol       Date:  2011-12-16       Impact factor: 25.083

2.  Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis.

Authors:  Jian Wang; Jingwu Li; Xiuchao Wang; Chen Zheng; Weidong Ma
Journal:  Biochem Biophys Res Commun       Date:  2013-08-17       Impact factor: 3.575

3.  Dysregulation of miR-15a and miR-214 in human pancreatic cancer.

Authors:  Xing J Zhang; Hua Ye; Cheng W Zeng; Bo He; Hua Zhang; Yue Q Chen
Journal:  J Hematol Oncol       Date:  2010-11-24       Impact factor: 17.388

4.  MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome.

Authors:  M G Narducci; D Arcelli; M C Picchio; C Lazzeri; E Pagani; F Sampogna; E Scala; P Fadda; C Cristofoletti; A Facchiano; M Frontani; A Monopoli; M Ferracin; M Negrini; G A Lombardo; E Caprini; G Russo
Journal:  Cell Death Dis       Date:  2011-04-28       Impact factor: 8.469

5.  Expression and function of angiopoietin-1 in breast cancer.

Authors:  A J Hayes; W Q Huang; J Yu; P C Maisonpierre; A Liu; F G Kern; M E Lippman; S W McLeskey; L Y Li
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

Review 6.  MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy.

Authors:  Kenneth K W To
Journal:  J Biomed Sci       Date:  2013-12-20       Impact factor: 8.410

7.  Let-7, mir-98 and mir-183 as biomarkers for cancer and schizophrenia [corrected].

Authors:  Emmanouil Rizos; Nikolaos Siafakas; Eleni Katsantoni; Eleni Skourti; Vassilios Salpeas; Ioannis Rizos; James N Tsoporis; Anastasia Kastania; Anastasia Filippopoulou; Nikolaos Xiros; Demetrios Margaritis; Thomas G Parker; Charalabos Papageorgiou; Vassilios Zoumpourlis
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

8.  Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway.

Authors:  Zhangxiao Peng; Yan Wang; Jianhui Fan; Xuejing Lin; Chunying Liu; Yang Xu; Weidan Ji; Chao Yan; Changqing Su
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

Review 9.  The role of MicroRNAs in human cancer.

Authors:  Yong Peng; Carlo M Croce
Journal:  Signal Transduct Target Ther       Date:  2016-01-28

10.  miR-98 targets ITGB3 to inhibit proliferation, migration, and invasion of non-small-cell lung cancer.

Authors:  Ran Ni; Yongjie Huang; Jing Wang
Journal:  Onco Targets Ther       Date:  2015-09-22       Impact factor: 4.147

View more
  5 in total

1.  HOXA11-AS induces cisplatin resistance by modulating the microRNA-98/PBX3 axis in nasopharyngeal carcinoma.

Authors:  Haineng Li; Jia Huang; Sa Yu; Hangbo Li; Yan Zhou; Qingwei Wu
Journal:  Oncol Lett       Date:  2021-04-26       Impact factor: 2.967

Review 2.  Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies.

Authors:  Mohammad Hasan Soheilifar; Nastaran Masoudi-Khoram; Soheil Madadi; Sima Nobari; Hamid Maadi; Hoda Keshmiri Neghab; Razieh Amini; Mahboubeh Pishnamazi
Journal:  J Adv Res       Date:  2021-06-26       Impact factor: 12.822

Review 3.  Angiogenesis-related non-coding RNAs and gastrointestinal cancer.

Authors:  Zahra Sadat Razavi; Kasra Asgarpour; Maryam Mahjoubin-Tehran; Susan Rasouli; Haroon Khan; Mohammad Karim Shahrzad; Michael R Hamblin; Hamed Mirzaei
Journal:  Mol Ther Oncolytics       Date:  2021-05-15       Impact factor: 7.200

4.  A Pilot Study on MicroRNA Profile in Tear Fluid to Predict Response to Anti-VEGF Treatments for Diabetic Macular Edema.

Authors:  Hwei Wuen Chan; Binxia Yang; Wendy Wong; Paul Blakeley; Ivan Seah; Queenie Shu Woon Tan; Haofei Wang; Mayuri Bhargava; Hazel Anne Lin; Charmaine Hc Chai; Erlangga Ariadarma Mangunkusumo; Naing Thet; Yew Sen Yuen; Raman Sethi; Si Wang; Walter Hunziker; Gopal Lingam; Xinyi Su
Journal:  J Clin Med       Date:  2020-09-10       Impact factor: 4.241

5.  SALL4 and microRNA: The Role of Let-7.

Authors:  Jun Liu; Madeline A Sauer; Shaza G Hussein; Junyu Yang; Daniel G Tenen; Li Chai
Journal:  Genes (Basel)       Date:  2021-08-24       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.